Interferon-ribavirin therapy induces serum antibodies determining 'rods and rings' pattern in hepatitis C patients

Cristina Novembrino, Alessio Aghemo, Chiara Ferraris Fusarini, Rita Maiavacca, Caterina Matinato, Giovanna Lunghi, Erminio Torresani, Mariangela Ronchi, Maria Cristina Garlaschi, Miriam Ramondetta, Massimo Colombo

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Summary A cytoplasmic antigen associated to inosine-5'-monophosphatedehydrogenase 2 eliciting specific antibodies (antirods and rings, RR) has been identified in patients with chronic hepatitis C who were exposed to pegylated interferon (PI) and ribavirin (RBV). The significance of anti-RR in these patients merits to be investigated. Sera from 88 chronic hepatitis C virus (HCV)-infected patients undergoing PI-RBV therapy were analysed for the presence of RR pattern by indirect immunofluorescence on HEp-2 substrate (Inova Diagnostics, San Diego, CA, USA). Anti-RR antibodies developed de novo in 32 patients independently of any demographic and virological feature, but with a significant association with cumulative exposure to PI-RBV (P = 0.0089; chi-square test). RR pattern was significantly more frequent in relapsers than in patients achieving sustained virological response (56% vs 30%; P = 0.0282, chi-square test). Anti-RR titre ranged from 1:80 to 1:1280, but significantly declined following treatment cessation. Anti-RR develop de novo in a substantial proportion of patients exposed to PI-RBV in relation to the duration of treatment exposure. Further investigations are necessary to unravel the mechanisms leading to the formation of these autoantibodies.

Original languageEnglish
Pages (from-to)944-949
Number of pages6
JournalJournal of Viral Hepatitis
Volume21
Issue number12
DOIs
Publication statusPublished - Dec 1 2014

Fingerprint

Ribavirin
Hepatitis C
Interferons
Antibodies
Serum
Chronic Hepatitis C
Chi-Square Distribution
Therapeutics
Inosine
Withholding Treatment
Indirect Fluorescent Antibody Technique
Hepacivirus
Autoantibodies
Anti-Idiotypic Antibodies
Demography
Antigens

Keywords

  • autoantibodies
  • hepatitis C virus
  • inosine-5'-monophosphatedehydrogenase 2
  • interferon
  • ribavirin

ASJC Scopus subject areas

  • Hepatology
  • Infectious Diseases
  • Virology
  • Medicine(all)

Cite this

Interferon-ribavirin therapy induces serum antibodies determining 'rods and rings' pattern in hepatitis C patients. / Novembrino, Cristina; Aghemo, Alessio; Ferraris Fusarini, Chiara; Maiavacca, Rita; Matinato, Caterina; Lunghi, Giovanna; Torresani, Erminio; Ronchi, Mariangela; Garlaschi, Maria Cristina; Ramondetta, Miriam; Colombo, Massimo.

In: Journal of Viral Hepatitis, Vol. 21, No. 12, 01.12.2014, p. 944-949.

Research output: Contribution to journalArticle

Novembrino, Cristina ; Aghemo, Alessio ; Ferraris Fusarini, Chiara ; Maiavacca, Rita ; Matinato, Caterina ; Lunghi, Giovanna ; Torresani, Erminio ; Ronchi, Mariangela ; Garlaschi, Maria Cristina ; Ramondetta, Miriam ; Colombo, Massimo. / Interferon-ribavirin therapy induces serum antibodies determining 'rods and rings' pattern in hepatitis C patients. In: Journal of Viral Hepatitis. 2014 ; Vol. 21, No. 12. pp. 944-949.
@article{cd56773060a84653b7b77f9be1550447,
title = "Interferon-ribavirin therapy induces serum antibodies determining 'rods and rings' pattern in hepatitis C patients",
abstract = "Summary A cytoplasmic antigen associated to inosine-5'-monophosphatedehydrogenase 2 eliciting specific antibodies (antirods and rings, RR) has been identified in patients with chronic hepatitis C who were exposed to pegylated interferon (PI) and ribavirin (RBV). The significance of anti-RR in these patients merits to be investigated. Sera from 88 chronic hepatitis C virus (HCV)-infected patients undergoing PI-RBV therapy were analysed for the presence of RR pattern by indirect immunofluorescence on HEp-2 substrate (Inova Diagnostics, San Diego, CA, USA). Anti-RR antibodies developed de novo in 32 patients independently of any demographic and virological feature, but with a significant association with cumulative exposure to PI-RBV (P = 0.0089; chi-square test). RR pattern was significantly more frequent in relapsers than in patients achieving sustained virological response (56{\%} vs 30{\%}; P = 0.0282, chi-square test). Anti-RR titre ranged from 1:80 to 1:1280, but significantly declined following treatment cessation. Anti-RR develop de novo in a substantial proportion of patients exposed to PI-RBV in relation to the duration of treatment exposure. Further investigations are necessary to unravel the mechanisms leading to the formation of these autoantibodies.",
keywords = "autoantibodies, hepatitis C virus, inosine-5'-monophosphatedehydrogenase 2, interferon, ribavirin",
author = "Cristina Novembrino and Alessio Aghemo and {Ferraris Fusarini}, Chiara and Rita Maiavacca and Caterina Matinato and Giovanna Lunghi and Erminio Torresani and Mariangela Ronchi and Garlaschi, {Maria Cristina} and Miriam Ramondetta and Massimo Colombo",
year = "2014",
month = "12",
day = "1",
doi = "10.1111/jvh.12281",
language = "English",
volume = "21",
pages = "944--949",
journal = "Journal of Viral Hepatitis",
issn = "1352-0504",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "12",

}

TY - JOUR

T1 - Interferon-ribavirin therapy induces serum antibodies determining 'rods and rings' pattern in hepatitis C patients

AU - Novembrino, Cristina

AU - Aghemo, Alessio

AU - Ferraris Fusarini, Chiara

AU - Maiavacca, Rita

AU - Matinato, Caterina

AU - Lunghi, Giovanna

AU - Torresani, Erminio

AU - Ronchi, Mariangela

AU - Garlaschi, Maria Cristina

AU - Ramondetta, Miriam

AU - Colombo, Massimo

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Summary A cytoplasmic antigen associated to inosine-5'-monophosphatedehydrogenase 2 eliciting specific antibodies (antirods and rings, RR) has been identified in patients with chronic hepatitis C who were exposed to pegylated interferon (PI) and ribavirin (RBV). The significance of anti-RR in these patients merits to be investigated. Sera from 88 chronic hepatitis C virus (HCV)-infected patients undergoing PI-RBV therapy were analysed for the presence of RR pattern by indirect immunofluorescence on HEp-2 substrate (Inova Diagnostics, San Diego, CA, USA). Anti-RR antibodies developed de novo in 32 patients independently of any demographic and virological feature, but with a significant association with cumulative exposure to PI-RBV (P = 0.0089; chi-square test). RR pattern was significantly more frequent in relapsers than in patients achieving sustained virological response (56% vs 30%; P = 0.0282, chi-square test). Anti-RR titre ranged from 1:80 to 1:1280, but significantly declined following treatment cessation. Anti-RR develop de novo in a substantial proportion of patients exposed to PI-RBV in relation to the duration of treatment exposure. Further investigations are necessary to unravel the mechanisms leading to the formation of these autoantibodies.

AB - Summary A cytoplasmic antigen associated to inosine-5'-monophosphatedehydrogenase 2 eliciting specific antibodies (antirods and rings, RR) has been identified in patients with chronic hepatitis C who were exposed to pegylated interferon (PI) and ribavirin (RBV). The significance of anti-RR in these patients merits to be investigated. Sera from 88 chronic hepatitis C virus (HCV)-infected patients undergoing PI-RBV therapy were analysed for the presence of RR pattern by indirect immunofluorescence on HEp-2 substrate (Inova Diagnostics, San Diego, CA, USA). Anti-RR antibodies developed de novo in 32 patients independently of any demographic and virological feature, but with a significant association with cumulative exposure to PI-RBV (P = 0.0089; chi-square test). RR pattern was significantly more frequent in relapsers than in patients achieving sustained virological response (56% vs 30%; P = 0.0282, chi-square test). Anti-RR titre ranged from 1:80 to 1:1280, but significantly declined following treatment cessation. Anti-RR develop de novo in a substantial proportion of patients exposed to PI-RBV in relation to the duration of treatment exposure. Further investigations are necessary to unravel the mechanisms leading to the formation of these autoantibodies.

KW - autoantibodies

KW - hepatitis C virus

KW - inosine-5'-monophosphatedehydrogenase 2

KW - interferon

KW - ribavirin

UR - http://www.scopus.com/inward/record.url?scp=84911406016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84911406016&partnerID=8YFLogxK

U2 - 10.1111/jvh.12281

DO - 10.1111/jvh.12281

M3 - Article

VL - 21

SP - 944

EP - 949

JO - Journal of Viral Hepatitis

JF - Journal of Viral Hepatitis

SN - 1352-0504

IS - 12

ER -